Note: Path Ex's revenues are gauged from an analysis of company filings.
Path Ex's Income Statement (based on Industry Averages)
Path Ex P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Path Ex has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
May 5, 2017
2
100%
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Path Ex is developing and marketing.
Path Ex doesn't have any recent trademark applications, indicating Path Ex is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
PATH EX Medical devices for the diagnosis and treatment of systemic infections and sepsis and in particular a fluidic device for purifying blood by removing materials from blood
06/12/2017
See all trademarks and details in the Full Report.
Market Share of Path Ex's Largest Competitors
A competitive analysis shows these companies are in the same general field as Path Ex, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Path Ex.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Path Ex and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.